The Global Veterinary Endocrinology Market size is expected to reach $482.2 million by 2031, rising at a market growth of 6.6% CAGR during the forecast period.
North America has a significant population of companion animals, including dogs, cats, and other pets. Thus, the North America region acquired 39% revenue share in the market 2023. The high prevalence of pets in households contributes to a larger pool of potential patients requiring specialized veterinary care, including endocrinology services. Pets in North America are often considered family members, leading to greater investments in their health and well-being. Pet owners prioritize preventive healthcare, advanced diagnostics, and specialized treatments, including veterinary endocrinology, to ensure their pets lead healthy and comfortable lives.
There's growing awareness among pet owners and veterinarians about various endocrine disorders that affect animals, such as diabetes mellitus, thyroid disorders, adrenal gland disorders, and reproductive hormone imbalances. This awareness leads to more animals being diagnosed and treated for these conditions.
Additionally, the global pet population, including dogs, cats, and exotic pets, continues to increase. This demographic trend directly correlates with a higher incidence of pet health issues, including endocrine disorders such as diabetes mellitus, thyroid disorders, and adrenal gland disorders. Therefore, increasing pet ownership and expenditures on pet healthcare drive the market's growth.
However, veterinary diagnostics and treatments for endocrine disorders can be expensive, especially when multiple diagnostic tests, specialized imaging studies, and ongoing treatment regimens are required. This can create financial constraints for pet owners, leading to hesitation or delay in seeking veterinary care. Thus, the high cost of diagnostic and treatment procedures impedes growth.
Route of Administration
Based on route of administration, the market is divided into oral and others. In 2023, the oral segment garnered 57.7% revenue share in the market. Oral medications are typically easier to administer than other forms, such as injections or transdermal treatments.
Animal Type Outlook
On the basis of animal type, the market is segmented into dogs, cats, and others. In 2023, the cats segment attained 30.7% revenue share in the market. The cat population, like the dog population, is aging due to advancements in veterinary medicine and nutrition.
Application Outlook
Based on application, the market is categorized into pancreatic disorders and others. In 2023, the pancreatic disorders segment registered 53.2% revenue share in the market. Pancreatic disorders often present with nonspecific clinical signs, making accurate diagnosis challenging.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Europe region generated 29.9% revenue share in the market. European veterinarians undergo rigorous training and education, often specializing in specific fields such as endocrinology.
List of Key Companies Profiled
- Dechra Pharmaceuticals PLC (EQT AB)
- Elanco Animal Health Incorporated
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- LLOYD, Inc.
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Mars, Inc. (Antech Diagnostics, Inc)
Global Veterinary Endocrinology Market Report Segmentation
By Route of Administration
By Animal Type
- Dogs,
- Cats, and
- Other Animals
By Application
- Pancreatic Disorders, and
- Other Disorders
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Veterinary Endocrinology Market, by Route of Administration
- 1.4.2 Global Veterinary Endocrinology Market, by Animal Type
- 1.4.3 Global Veterinary Endocrinology Market, by Application
- 1.4.4 Global Veterinary Endocrinology Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Global Veterinary Endocrinology Market by Route of Administration
- 4.1 Global Oral Market by Region
- 4.2 Global Others Market by Region
Chapter 5. Global Veterinary Endocrinology Market by Animal Type
- 5.1 Global Dogs Market by Region
- 5.2 Global Cats Market by Region
- 5.3 Global Others Market by Region
Chapter 6. Global Veterinary Endocrinology Market by Application
- 6.1 Global Pancreatic Disorders Market by Region
- 6.2 Global Others Market by Region
Chapter 7. Global Veterinary Endocrinology Market by Region
- 7.1 North America Veterinary Endocrinology Market
- 7.1.1 North America Veterinary Endocrinology Market by Route of Administration
- 7.1.1.1 North America Oral Market by Region
- 7.1.1.2 North America Others Market by Region
- 7.1.2 North America Veterinary Endocrinology Market by Animal Type
- 7.1.2.1 North America Dogs Market by Country
- 7.1.2.2 North America Cats Market by Country
- 7.1.2.3 North America Others Market by Country
- 7.1.3 North America Veterinary Endocrinology Market by Application
- 7.1.3.1 North America Pancreatic Disorders Market by Country
- 7.1.3.2 North America Others Market by Country
- 7.1.4 North America Veterinary Endocrinology Market by Country
- 7.1.4.1 US Veterinary Endocrinology Market
- 7.1.4.1.1 US Veterinary Endocrinology Market by Route of Administration
- 7.1.4.1.2 US Veterinary Endocrinology Market by Animal Type
- 7.1.4.1.3 US Veterinary Endocrinology Market by Application
- 7.1.4.2 Canada Veterinary Endocrinology Market
- 7.1.4.2.1 Canada Veterinary Endocrinology Market by Route of Administration
- 7.1.4.2.2 Canada Veterinary Endocrinology Market by Animal Type
- 7.1.4.2.3 Canada Veterinary Endocrinology Market by Application
- 7.1.4.3 Mexico Veterinary Endocrinology Market
- 7.1.4.3.1 Mexico Veterinary Endocrinology Market by Route of Administration
- 7.1.4.3.2 Mexico Veterinary Endocrinology Market by Animal Type
- 7.1.4.3.3 Mexico Veterinary Endocrinology Market by Application
- 7.1.4.4 Rest of North America Veterinary Endocrinology Market
- 7.1.4.4.1 Rest of North America Veterinary Endocrinology Market by Route of Administration
- 7.1.4.4.2 Rest of North America Veterinary Endocrinology Market by Animal Type
- 7.1.4.4.3 Rest of North America Veterinary Endocrinology Market by Application
- 7.2 Europe Veterinary Endocrinology Market
- 7.2.1 Europe Veterinary Endocrinology Market by Route of Administration
- 7.2.1.1 Europe Oral Market by Country
- 7.2.1.2 Europe Others Market by Country
- 7.2.2 Europe Veterinary Endocrinology Market by Animal Type
- 7.2.2.1 Europe Dogs Market by Country
- 7.2.2.2 Europe Cats Market by Country
- 7.2.2.3 Europe Others Market by Country
- 7.2.3 Europe Veterinary Endocrinology Market by Application
- 7.2.3.1 Europe Pancreatic Disorders Market by Country
- 7.2.3.2 Europe Others Market by Country
- 7.2.4 Europe Veterinary Endocrinology Market by Country
- 7.2.4.1 Germany Veterinary Endocrinology Market
- 7.2.4.1.1 Germany Veterinary Endocrinology Market by Route of Administration
- 7.2.4.1.2 Germany Veterinary Endocrinology Market by Animal Type
- 7.2.4.1.3 Germany Veterinary Endocrinology Market by Application
- 7.2.4.2 UK Veterinary Endocrinology Market
- 7.2.4.2.1 UK Veterinary Endocrinology Market by Route of Administration
- 7.2.4.2.2 UK Veterinary Endocrinology Market by Animal Type
- 7.2.4.2.3 UK Veterinary Endocrinology Market by Application
- 7.2.4.3 France Veterinary Endocrinology Market
- 7.2.4.3.1 France Veterinary Endocrinology Market by Route of Administration
- 7.2.4.3.2 France Veterinary Endocrinology Market by Animal Type
- 7.2.4.3.3 France Veterinary Endocrinology Market by Application
- 7.2.4.4 Russia Veterinary Endocrinology Market
- 7.2.4.4.1 Russia Veterinary Endocrinology Market by Route of Administration
- 7.2.4.4.2 Russia Veterinary Endocrinology Market by Animal Type
- 7.2.4.4.3 Russia Veterinary Endocrinology Market by Application
- 7.2.4.5 Spain Veterinary Endocrinology Market
- 7.2.4.5.1 Spain Veterinary Endocrinology Market by Route of Administration
- 7.2.4.5.2 Spain Veterinary Endocrinology Market by Animal Type
- 7.2.4.5.3 Spain Veterinary Endocrinology Market by Application
- 7.2.4.6 Italy Veterinary Endocrinology Market
- 7.2.4.6.1 Italy Veterinary Endocrinology Market by Route of Administration
- 7.2.4.6.2 Italy Veterinary Endocrinology Market by Animal Type
- 7.2.4.6.3 Italy Veterinary Endocrinology Market by Application
- 7.2.4.7 Rest of Europe Veterinary Endocrinology Market
- 7.2.4.7.1 Rest of Europe Veterinary Endocrinology Market by Route of Administration
- 7.2.4.7.2 Rest of Europe Veterinary Endocrinology Market by Animal Type
- 7.2.4.7.3 Rest of Europe Veterinary Endocrinology Market by Application
- 7.3 Asia Pacific Veterinary Endocrinology Market
- 7.3.1 Asia Pacific Veterinary Endocrinology Market by Route of Administration
- 7.3.1.1 Asia Pacific Oral Market by Country
- 7.3.1.2 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific Veterinary Endocrinology Market by Animal Type
- 7.3.2.1 Asia Pacific Dogs Market by Country
- 7.3.2.2 Asia Pacific Cats Market by Country
- 7.3.2.3 Asia Pacific Others Market by Country
- 7.3.3 Asia Pacific Veterinary Endocrinology Market by Application
- 7.3.3.1 Asia Pacific Pancreatic Disorders Market by Country
- 7.3.3.2 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Veterinary Endocrinology Market by Country
- 7.3.4.1 China Veterinary Endocrinology Market
- 7.3.4.1.1 China Veterinary Endocrinology Market by Route of Administration
- 7.3.4.1.2 China Veterinary Endocrinology Market by Animal Type
- 7.3.4.1.3 China Veterinary Endocrinology Market by Application
- 7.3.4.2 Japan Veterinary Endocrinology Market
- 7.3.4.2.1 Japan Veterinary Endocrinology Market by Route of Administration
- 7.3.4.2.2 Japan Veterinary Endocrinology Market by Animal Type
- 7.3.4.2.3 Japan Veterinary Endocrinology Market by Application
- 7.3.4.3 India Veterinary Endocrinology Market
- 7.3.4.3.1 India Veterinary Endocrinology Market by Route of Administration
- 7.3.4.3.2 India Veterinary Endocrinology Market by Animal Type
- 7.3.4.3.3 India Veterinary Endocrinology Market by Application
- 7.3.4.4 South Korea Veterinary Endocrinology Market
- 7.3.4.4.1 South Korea Veterinary Endocrinology Market by Route of Administration
- 7.3.4.4.2 South Korea Veterinary Endocrinology Market by Animal Type
- 7.3.4.4.3 South Korea Veterinary Endocrinology Market by Application
- 7.3.4.5 Australia Veterinary Endocrinology Market
- 7.3.4.5.1 Australia Veterinary Endocrinology Market by Route of Administration
- 7.3.4.5.2 Australia Veterinary Endocrinology Market by Animal Type
- 7.3.4.5.3 Australia Veterinary Endocrinology Market by Application
- 7.3.4.6 Malaysia Veterinary Endocrinology Market
- 7.3.4.6.1 Malaysia Veterinary Endocrinology Market by Route of Administration
- 7.3.4.6.2 Malaysia Veterinary Endocrinology Market by Animal Type
- 7.3.4.6.3 Malaysia Veterinary Endocrinology Market by Application
- 7.3.4.7 Rest of Asia Pacific Veterinary Endocrinology Market
- 7.3.4.7.1 Rest of Asia Pacific Veterinary Endocrinology Market by Route of Administration
- 7.3.4.7.2 Rest of Asia Pacific Veterinary Endocrinology Market by Animal Type
- 7.3.4.7.3 Rest of Asia Pacific Veterinary Endocrinology Market by Application
- 7.4 LAMEA Veterinary Endocrinology Market
- 7.4.1 LAMEA Veterinary Endocrinology Market by Route of Administration
- 7.4.1.1 LAMEA Oral Market by Country
- 7.4.1.2 LAMEA Others Market by Country
- 7.4.2 LAMEA Veterinary Endocrinology Market by Animal Type
- 7.4.2.1 LAMEA Dogs Market by Country
- 7.4.2.2 LAMEA Cats Market by Country
- 7.4.2.3 LAMEA Others Market by Country
- 7.4.3 LAMEA Veterinary Endocrinology Market by Application
- 7.4.3.1 LAMEA Pancreatic Disorders Market by Country
- 7.4.3.2 LAMEA Others Market by Country
- 7.4.4 LAMEA Veterinary Endocrinology Market by Country
- 7.4.4.1 Brazil Veterinary Endocrinology Market
- 7.4.4.1.1 Brazil Veterinary Endocrinology Market by Route of Administration
- 7.4.4.1.2 Brazil Veterinary Endocrinology Market by Animal Type
- 7.4.4.1.3 Brazil Veterinary Endocrinology Market by Application
- 7.4.4.2 Argentina Veterinary Endocrinology Market
- 7.4.4.2.1 Argentina Veterinary Endocrinology Market by Route of Administration
- 7.4.4.2.2 Argentina Veterinary Endocrinology Market by Animal Type
- 7.4.4.2.3 Argentina Veterinary Endocrinology Market by Application
- 7.4.4.3 UAE Veterinary Endocrinology Market
- 7.4.4.3.1 UAE Veterinary Endocrinology Market by Route of Administration
- 7.4.4.3.2 UAE Veterinary Endocrinology Market by Animal Type
- 7.4.4.3.3 UAE Veterinary Endocrinology Market by Application
- 7.4.4.4 Saudi Arabia Veterinary Endocrinology Market
- 7.4.4.4.1 Saudi Arabia Veterinary Endocrinology Market by Route of Administration
- 7.4.4.4.2 Saudi Arabia Veterinary Endocrinology Market by Animal Type
- 7.4.4.4.3 Saudi Arabia Veterinary Endocrinology Market by Application
- 7.4.4.5 South Africa Veterinary Endocrinology Market
- 7.4.4.5.1 South Africa Veterinary Endocrinology Market by Route of Administration
- 7.4.4.5.2 South Africa Veterinary Endocrinology Market by Animal Type
- 7.4.4.5.3 South Africa Veterinary Endocrinology Market by Application
- 7.4.4.6 Nigeria Veterinary Endocrinology Market
- 7.4.4.6.1 Nigeria Veterinary Endocrinology Market by Route of Administration
- 7.4.4.6.2 Nigeria Veterinary Endocrinology Market by Animal Type
- 7.4.4.6.3 Nigeria Veterinary Endocrinology Market by Application
- 7.4.4.7 Rest of LAMEA Veterinary Endocrinology Market
- 7.4.4.7.1 Rest of LAMEA Veterinary Endocrinology Market by Route of Administration
- 7.4.4.7.2 Rest of LAMEA Veterinary Endocrinology Market by Animal Type
- 7.4.4.7.3 Rest of LAMEA Veterinary Endocrinology Market by Application
Chapter 8. Company Profiles
- 8.1 Dechra Pharmaceuticals PLC
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental & Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Elanco Animal Health, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
- 8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 Boehringer Ingelheim International GmbH
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional & Segmental Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
- 8.5 Zoetis, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
- 8.6 LLOYD, Inc.
- 8.6.1 Company Overview
- 8.6.2 SWOT Analysis
- 8.7 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- 8.7.1 Company Overview
- 8.7.2 SWOT Analysis
- 8.8 Mars, Inc. (Antech Diagnostics, Inc)
- 8.8.1 Company Overview
- 8.8.2 SWOT Analysis
Chapter 9. Winning Imperatives for Veterinary Endocrinology Market